Oxy klinika, MB - financials and debts

Company age: 5 y. 6 mo.

Update

Oxy klinika - Company finances

EUR
2021
From: 2021-03-08
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 16,000 61,574 78,322 106,210 148,839
Profit before tax 230 3,610 16,902 704 17,945
Net profit 183 3,429 15,914 327 16,313
Equity 283 3,712 19,626 19,953 36,265
Liabilities - 4,268 14,269 19,796 10,119
Non-current assets 0 0 0 0 0
Current assets 6,270 7,980 33,895 39,749 46,384
Total assets 6,270 7,980 33,895 39,749 46,384
Taxes paid
STI taxes - - 4,883 2,544 3,685
Financial indicators
Revenue change y/y - +284.8% +27.2% +35.6% +40.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 2.9% 43.0% 47.0% 0.8% 35.2%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 64.7% 92.4% 81.1% 1.6% 45.0%
Profit margin Net profit margin. Shows the overall profitability of the company. 1.1% 5.6% 20.3% 0.3% 11.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 1.4% 5.9% 21.6% 0.7% 12.1%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 1.1 0.7 1.0 0.3
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 16,000 48,381 42,722 106,210 148,839

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Oxy klinika - Social security debts

From To Debt, €
2026-09-05 2026-09-14 46.35
2026-08-26 2026-09-02 46.35
2026-08-23 2026-08-23 46.35
2026-08-19 2026-08-19 46.35
2026-08-16 2026-08-16 46.35
2026-07-26 2026-08-14 46.35
2026-07-23 2026-07-25 46.46
2026-07-19 2026-07-22 46.35
2026-07-16 2026-07-17 46.35
2025-06-17 2025-06-18 2.88
2025-06-11 2025-06-15 2.88
2025-06-08 2025-06-09 2.88
2025-05-16 2025-06-04 2.88
2025-05-04 2025-05-14 2.88
2025-04-30 2025-04-30 2.84
2025-04-24 2025-04-29 2.88
2025-04-16 2025-04-23 2.84
2025-03-18 2025-04-14 2.84
2025-02-18 2025-03-16 2.84
2025-01-22 2025-02-16 2.84
2025-01-16 2025-01-21 2.79
2025-01-02 2025-01-12 2.79
2024-12-22 2024-12-31 2.79
2024-10-24 2024-12-20 2.79
2024-09-17 2024-10-23 1.83
2024-08-19 2024-09-16 2.13
2024-07-26 2024-08-18 0.14
2024-07-24 2024-07-25 225.45
2024-07-16 2024-07-23 225.31
2024-03-18 2024-06-13 0.62
2024-02-19 2024-03-14 0.62
2024-01-15 2024-02-14 0.62
2023-10-25 2024-01-11 0.62
2023-07-24 2023-10-24 0.15
2023-07-18 2023-07-23 544.19
2023-05-16 2023-06-04 8.94
2023-05-02 2023-05-15 0.31
2023-04-26 2023-04-28 0.31
2023-04-18 2023-04-25 0.09
2023-02-06 2023-04-16 0.09
2023-01-24 2023-02-03 0.09
2022-11-21 2022-11-30 0.28
2022-11-17 2022-11-18 0.28
2022-10-28 2022-11-16 0.29
2022-06-16 2022-07-17 0.33
2022-05-17 2022-06-14 0.33
2022-04-28 2022-05-15 0.33
2022-02-17 2022-02-20 155.51
2022-01-31 2022-02-16 0.24
2021-12-16 2021-12-19 136.55

Oxy klinika - VMI tax arrears

As of 2026-09-02, the amount of overdue STI tax debt of the company Oxy klinika is: 7 €

From To Overdue, €
2026-08-31 2026-09-02 7.04
2026-08-17 2026-08-30 7.2
2026-08-12 2026-08-16 8.11
2026-08-02 2026-08-11 7.2
2026-07-02 2026-08-01 6.75
2026-06-18 2026-07-01 1654.6
2026-03-27 2026-06-17 1.6
2026-03-20 2026-03-26 3.2
2026-01-16 2026-03-08 1.6
2025-08-01 2026-01-15 2.4
2025-07-17 2025-07-31 1.4
2025-07-08 2025-07-16 180.3
2025-07-03 2025-07-07 1.4
2025-07-01 2025-07-02 380.83
2025-06-19 2025-06-30 379.43
2025-05-24 2025-06-18 2.43
2025-05-17 2025-05-23 1006.33
2025-05-06 2025-05-16 2000.0
2025-04-30 2025-05-05 2475.0
2024-09-30 2024-10-09 11.68

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Oxy klinika, MB (code 305710498) is a Lithuanian small partnership engaged in other human health activities n.e.c. In 2025, the company generated revenue of €148.8K, up 40.1% year on year and 90.0% over two years. Net profit in 2025 was €16.3K, compared with €327 in 2024 and €15.9K in 2023, showing a strong recovery after a very weak 2024 result. The 2025 profit margin improved to 11.0%, from 0.3% in 2024, though it remained below the 20.3% achieved in 2023. Balance-sheet structure strengthened during 2025: total assets increased to €46.4K from €39.7K a year earlier, while equity rose to €36.3K and liabilities declined to €10.1K. The equity ratio was 78.2%, and debt to equity was 0.28, indicating a relatively light balance-sheet burden. Asset turnover reached 3.21x, supported by the higher revenue base. Revenue per employee was €148.8K and profit per employee was €16.3K for 2025.